Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
B Tavora, LE Reynolds, S Batista, F Demircioglu… - Nature, 2014 - nature.com
Chemoresistance is a serious limitation of cancer treatment. Until recently, almost all the
work done to study this limitation has been restricted to tumour cells. Here we identify a …
work done to study this limitation has been restricted to tumour cells. Here we identify a …
Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy.
B Tavora, A Alexopoulou, KM Hodivala-Dilke… - …, 2014 - search.ebscohost.com
Chemoresistance is a serious limitation of cancer treatment. Until recently, almost all the
work done to study this limitation has been restricted to tumour cells. Here we identify a …
work done to study this limitation has been restricted to tumour cells. Here we identify a …
Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
B Tavora, LE Reynolds, S Batista, F Demircioglu… - …, 2014 - ui.adsabs.harvard.edu
Chemoresistance is a serious limitation of cancer treatment. Until recently, almost all the
work done to study this limitation has been restricted to tumour cells. Here we identify a …
work done to study this limitation has been restricted to tumour cells. Here we identify a …
Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
B Tavora, LE Reynolds, S Batista, F Demircioglu… - Nature, 2014 - go.gale.com
Chemoresistance is a serious limitation of cancer treatment (1). Until recently, almost all the
work done to study this limitation has been restricted to tumour cells (2). Here we identify a …
work done to study this limitation has been restricted to tumour cells (2). Here we identify a …
Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
B Tavora, LE Reynolds, S Batista, F Demircioglu… - Nature, 2014 - eprints.ncl.ac.uk
Chemoresistance is a serious limitation of cancer treatment (1). Until recently, almost all the
work done to study this limitation has been restricted to tumour cells (2). Here we identify a …
work done to study this limitation has been restricted to tumour cells (2). Here we identify a …
[HTML][HTML] Endothelial–cell FAK targeting sensitizes tumours to DNA–damaging therapy
B Tavora, LE Reynolds, S Batista, F Demircioglu… - Nature, 2014 - ncbi.nlm.nih.gov
Chemoresistance is a serious limitation of cancer treatment 1. Until recently, almost all the
work done to study this limitation has been restricted to tumour cells 2. Here we identify a …
work done to study this limitation has been restricted to tumour cells 2. Here we identify a …
Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy.
B Tavora, LE Reynolds, S Batista, F Demircioglu… - Nature, 2014 - europepmc.org
Chemoresistance is a serious limitation of cancer treatment 1. Until recently, almost all the
work done to study this limitation has been restricted to tumour cells 2. Here we identify a …
work done to study this limitation has been restricted to tumour cells 2. Here we identify a …
Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
B Tavora, LE Reynolds, S Batista, F Demircioglu… - Nature, 2014 - econpapers.repec.org
The tumour microenvironment can influence its response to anticancer therapies; here, the
enzyme FAK in endothelial cells is shown to have a role in the induction of a number of …
enzyme FAK in endothelial cells is shown to have a role in the induction of a number of …
Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
B Tavora, LE Reynolds, S Batista, F Demircioglu… - Nature, 2014 - ideas.repec.org
The tumour microenvironment can influence its response to anticancer therapies; here, the
enzyme FAK in endothelial cells is shown to have a role in the induction of a number of …
enzyme FAK in endothelial cells is shown to have a role in the induction of a number of …
[引用][C] Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
B Tavora, LE Reynolds, S Batista, F Demircioglu… - Nature, 2014 - cir.nii.ac.jp